Court reportedly to grant prelim approval to Bayer (BAYN GY) roundup settlement
Newsquawk Staff ·
Court reportedly to grant prelim approval to Bayer (BAYN GY) roundup settlement.
What it means
The court's preliminary approval of Bayer's Roundup settlement could alleviate legal uncertainties that have weighed on the stock, potentially supporting a rebound in investor sentiment. While there may be lingering concerns regarding total liabilities and future settlements, this step is a positive signal for Bayer’s ongoing restructuring efforts. Keep an eye on how this might influence peer valuations in the pharmaceuticals sector and overall investor appetite going forward.
- T-Mobile (TMUS) CEO to step down from the board
- Daily US Conference Calendar - 28th October 2026: JNJ, BA, CAT
- Mercedes-Benz Group (MBG GY) CEO says the Co. is preparing a broader strategy update covering 2030 and beyond, with China remaining a core pillar of its long-term plans
- Eli Lilly’s (LLY) retatrutide delivered greater A1C reduction and more than double the weight loss of Novo Nordisk’s (NOVOB DC) Ozempic at its highest approved dose in head-to-head trial
- Santander (SAN SM) Q3 (EUR) net 3.43bln (exp. 3.41bln), rev. 16.0bln (prev. 15.3bln Y/Y)
Related headlines
- PRE-MARKET INDIAN STOCKS NEWS: Earnings deluge and Jio Platforms debut11 hours ago
- UK confirms it will be removing the standing charge on gas bills. Ofgem will be directed to do this in 2027, or as soon as possible8 hours ago
- Stellantis (STLAM IM) earnings call summary: Co. firmly believes will beat initial goal of EUR 2.4bln cost savings in 20272 hours ago
- [MARKET ANALYSIS] Asia-Pac stocks are higher amid the ongoing tech rebound and record SK Hynix earnings, while participants await central bank decisions11 hours ago
- Qatar has not presented a new proposal to end hostilities between Iran and the US, Reuters reports, citing a senior Iranian official; Tehran's policy of showing no flexibility over the nuclear issue remains unchanged4 hours ago
- Biogen Inc. (BIIB) Q3 2026 (USD): Adj. EPS 2.62 (exp. 1.98), Revenue 2.8bln (exp. 2.63bln). Raises lower end of FY26 diluted EPS guidance to USD 12.20-13.00 (exp. 12.23, prev. 12.00-13.00)4 hours ago
- Al-Mayadeen correspondent in Iran says Iranian officials believe that Trump wants to bring the nuclear issue into the negotiations, which Iran rejects1 hour ago
- Senior US Treasury trade official Eric Ettorre will leave to join Netflix (NFLX), reports Axios1 hour ago
- US Midterms (6 days out): Florida flips to a Republican early-vote lead and Kansas narrows further; Crystal Ball shifts House and Senate races towards Democrats2 hours ago
- US President Trump says there will be a meeting with Russian President Putin and Ukrainian President Zelensky set up soon, while Trump says there will be a meeting on disarmament during Asia trip10 hours ago
- [MARKET UPDATE] Limited Gilt reaction on the Chancellor's speech. Upside in Gilts on the DMO remit, size as expected and marked skew away from long-end. OBR commentary then pared some of this.1 hour ago
- Ukrainian President Zelensky says negotiations between Ukraine, Russia and the US could take place as early as November 10th2 hours ago
- Israeli election results show Netanyahu's bloc with 53 seats, Eisenkot's bloc with 47 and Arab parties with 19, following the counting of all votes excluding double-envelope ballots, i24 reports2 hours ago
- UK PM Burnham declines to rule out another Brexit referendum at PMQs2 hours ago
- Atomic Energy Organization of Iran Spokesman says protocol for building small reactors with Russia is being finalized3 hours ago